Research Articles
miRNA-Activated CRISPR Editing: Programming Cell-Specific Therapeutics for Precision Medicine
This article explores the emerging field of miRNA-activated CRISPR-Cas9 systems, a revolutionary class of gene-editing tools designed for cell-specific control.
Tissue-Specific CRISPR Delivery: Methods, Challenges, and Clinical Translation
The therapeutic potential of CRISPR gene editing is immense, but its clinical application hinges on the efficient and specific delivery of editing machinery to target tissues.
Beyond Cas9: Discovering Novel CRISPR Systems and Their AI-Driven Future in Biomedicine
The discovery of novel CRISPR systems is rapidly moving beyond the foundational Cas9 enzyme, propelled by metagenomic mining and artificial intelligence.
A Comprehensive Guide to CRISPR Array Identification Tools: From Foundational Concepts to Clinical Applications
This article provides a systematic overview of the bioinformatics tools essential for identifying and analyzing CRISPR arrays, a cornerstone of prokaryotic adaptive immunity and genome-editing technologies.
dCas9 in Gene Regulation: From CRISPRa and CRISPRi Mechanisms to Therapeutic Applications
This article provides a comprehensive overview of the mechanisms and applications of catalytically dead Cas9 (dCas9) in programmable gene regulation.
CRISPR Synthetic Biology Tools: A 2025 Review of Mechanisms, Applications, and Clinical Translation
This review comprehensively examines the rapidly evolving landscape of CRISPR-based synthetic biology tools, tailored for researchers and drug development professionals.
Unlocking CRISPR's Potential: A Comprehensive Guide to PAM Discovery and Its Impact on Therapeutic Development
Protospacer Adjacent Motif (PAM) discovery is a critical frontier in expanding CRISPR-Cas genome editing capabilities for research and therapeutic applications.
CRISPRa vs CRISPRi: Mechanisms, Applications, and Optimization for Precision Genetic Control
This article provides a comprehensive comparison of CRISPR activation (CRISPRa) and CRISPR interference (CRISPRi) technologies for researchers and drug development professionals.
Evaluating Zero-Shot Predictors in the DBTL Cycle: A Framework for Accelerating Biomedical Discovery
This article provides a comprehensive framework for researchers and drug development professionals to evaluate and integrate zero-shot predictors into the Design-Build-Test-Learn (DBTL) cycle.
LDBT vs DBTL: How Machine Learning is Redefining the Synthetic Biology Cycle
This article explores the paradigm shift from the traditional Design-Build-Test-Learn (DBTL) cycle to a new Learn-Design-Build-Test (LDBT) framework in synthetic biology.